Press Releases

Active Biotech's Prostate Cancer Project TASQ Featured in British Journal of Cancer
September 25, 2009 08:30 (CEST)
Active Biotech to Present at the UBS Global Life Sciences Conference
September 17, 2009 14:00 (CEST)
LAQUINIMOD IMMUNOMODULATORY ACTION CONFERS BOTH NEUROPROTECTIVE AND ANTI-INFLAMMATORY PROPERTIES
September 11, 2009 15:30 (CEST)
Laquinimod presentations at ECTRIMS
September 8, 2009 16:16 (CEST)
Active Biotech to Present at the Rodman & Renshaw 11th Annual Healthcare Conference
September 4, 2009 08:30 (CEST)
New information regarding RhuDex(TM)
August 7, 2009 08:30 (CEST)
Active Biotech AB Interim report January-June 2009
August 6, 2009 08:30 (CEST)
Active Biotech's Cancer Project ANYARA Featured in Journal of Clinical Oncology
July 28, 2009 08:30 (CEST)
Number of shares and votes in Active Biotech
June 30, 2009 08:30 (CEST)
Teva Completes Enrollment in Second Oral Laquinimod Phase III MS Clinical Trial
June 25, 2009 14:00 (CEST)